Literature DB >> 20348003

Principles and problems of the electrophoretic mobility shift assay.

Neil S Holden1, Claire E Tacon.   

Abstract

INTRODUCTION: The electrophoretic mobility shift assay (EMSA) is classically used to detect DNA binding proteins, the tenet of the EMSA is that DNA with protein bound, migrates through a polyacrylamide gel more slowly than the corresponding free unbound DNA.
METHODS: The classical EMSA protocol has 4 major steps: 1) The isolation of proteins from cells. Since the vast majority of active DNA binding proteins are present within the nucleus, a sequential membrane lysis protocol is used which yields purified nuclear protein. 2) Manufacture and radiolabelling of the DNA probe. Phosphorous 32 ((32)P) is attached to the 5' ends of the DNA probe through use of (32)P-γATP as a substrate for T4 polynucleotide kinase. DNA probes can both be purchased or custom made. 3) Purified proteins and radiolabelled DNA probes are co-incubated with an EMSA binding buffer to promote binding of the proteins with the DNA probe. If a supershift EMSA is being carried out, the reaction also contains a selective antibody which when bound to the protein-DNA complexes, causes further retardation within the gel. 4) The DNA-protein complexes are loaded and run on a non-denaturing polyacrylamide gel causing separation of the DNA-protein complexes from the free DNA probes. The polyacrylamide gels are then dried down and analysed via autoradiography.
RESULTS: As a demonstration of the effectiveness of this protocol, we show that tumour necrosis factor (TNF)α and phorbol 12-myristate 13-acetate (PMA) stimulation of A549 cells, results in a number of DNA-protein complexes being induced when compared to untreated cells. We also demonstrate that these complexes contain the p50 and p65 subunits of NF-κB through utilisation of the EMSA supershift protocol. DISCUSSION: We provide detailed troubleshooting hints and tips for this technique and discuss the limitations of the EMSA, as well as a number of EMSA variants and alternative techniques.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20348003     DOI: 10.1016/j.vascn.2010.03.002

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  19 in total

1.  NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells.

Authors:  Jonathan M Mendez; A Marijke Keestra-Gounder
Journal:  J Vis Exp       Date:  2020-01-12       Impact factor: 1.355

2.  PPARγ inhibits airway epithelial cell inflammatory response through a MUC1-dependent mechanism.

Authors:  Yong Sung Park; Erik P Lillehoj; Kosuke Kato; Choon Sik Park; Kwang Chul Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-20       Impact factor: 5.464

3.  Measurement of NF-κB Activation in TLR-Activated Macrophages.

Authors:  Orna Ernst; Sharat J Vayttaden; Iain D C Fraser
Journal:  Methods Mol Biol       Date:  2018

4.  Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA).

Authors:  Daniel E Miller; Zubin H Patel; Xiaoming Lu; Arthur T Lynch; Matthew T Weirauch; Leah C Kottyan
Journal:  J Vis Exp       Date:  2016-08-21       Impact factor: 1.355

5.  Development of novel CH223191-based antagonists of the aryl hydrocarbon receptor.

Authors:  Eun-Young Choi; Hyosung Lee; R W Cameron Dingle; Kyung Bo Kim; Hollie I Swanson
Journal:  Mol Pharmacol       Date:  2011-10-03       Impact factor: 4.436

6.  Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1.

Authors:  Marcela Cataldi; Nirav R Shah; Sébastien A Felt; Valery Z Grdzelishvili
Journal:  Virology       Date:  2015-08-29       Impact factor: 3.616

7.  Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication.

Authors:  Yuqing Li; Xubing Long; Lu Huang; Mengtian Yang; Yan Yuan; Yan Wang; Henri-Jacques Delecluse; Ersheng Kuang
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

8.  Evaluation of 3-(3-chloro-phenyl)-5-(4-pyridyl)-4,5-dihydroisoxazole as a novel anti-inflammatory drug candidate.

Authors:  Amanda Roberta Revoredo Vicentino; Vitor Coutinho Carneiro; Anderson de Mendonça Amarante; Claudia Farias Benjamim; Alcino Palermo de Aguiar; Marcelo Rosado Fantappié
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

Review 9.  Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System.

Authors:  Marina Mostafizar; Claudia Cortes-Pérez; Wanda Snow; Jelena Djordjevic; Aida Adlimoghaddam; Benedict C Albensi
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

10.  A network of HMG-box transcription factors regulates sexual cycle in the fungus Podospora anserina.

Authors:  Jinane Ait Benkhali; Evelyne Coppin; Sylvain Brun; Leonardo Peraza-Reyes; Tom Martin; Christina Dixelius; Noureddine Lazar; Herman van Tilbeurgh; Robert Debuchy
Journal:  PLoS Genet       Date:  2013-07-18       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.